Tenaya Therapeutics (TNYA) Interest Coverage Ratio (2020 - 2026)
Tenaya Therapeutics' (TNYA) quarterly Interest Coverage Ratio came in at 9.78 in Q1 2026, up 64.88% year-on-year from 5.93 in Q1 2025, and up 55.43% quarter-over-quarter from 21.94 in Q4 2025.
Tenaya Therapeutics (TNYA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 9.78 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 64.88% year-over-year to 9.78 in Q1 2026; TTM through Mar 2026 was 41.84, a 87.08% decrease from a year earlier, with the FY2025 full-year figure at 0.64, up 30.41% from the prior year.
- Interest Coverage Ratio advanced to 9.78 in Q1 2026 per TNYA's latest filing, from 21.94 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1.27 in Q2 2022 and bottomed at 8637.5 in Q4 2022.
- The 5-year median for Interest Coverage Ratio is 8.52 (2023), against an average of 518.36.
- Across the five-year window, Interest Coverage Ratio plunged 55592.79% in 2022 and soared 99.73% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 8637.5 in 2022, then jumped by 99.73% to 23.35 in 2023, then gained by 14.7% to 19.91 in 2024, then retreated by 10.17% to 21.94 in 2025, then surged by 55.43% to 9.78 in 2026.
- Per Business Quant, the three latest TNYA Interest Coverage Ratio figures stand at 9.78 (Q1 2026), 21.94 (Q4 2025), and 1.49 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Tenaya Therapeutics | 167.00 Mn | 167.00 Mn | - | -9.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.78 |
| Dec 31, 2025 | -21.94 |
| Sep 30, 2025 | -1.49 |
| Jun 30, 2025 | -1.60 |
| Mar 31, 2025 | -27.84 |
| Dec 31, 2024 | -19.91 |
| Sep 30, 2024 | -1.47 |
| Jun 30, 2024 | -1.57 |
| Mar 31, 2024 | -25.35 |
| Dec 31, 2023 | -23.35 |
| Sep 30, 2023 | -1.95 |
| Jun 30, 2023 | -8.52 |
| Mar 31, 2023 | -25.64 |
| Dec 31, 2022 | -8,637.50 |
| Sep 30, 2022 | -1.48 |
| Jun 30, 2022 | -1.27 |
| Mar 31, 2022 | -1.47 |
| Dec 31, 2021 | -15.51 |
| Sep 30, 2021 | -0.51 |
| Jun 30, 2021 | -0.90 |